PRDX3 and breast carcinoma: Knockdown of PRDX3 expression in triple negative basal B MDA-MB-231 and BT-549 breast cancer cells inhibited cell migratory and invasive potential, demonstrating the oncogenic role of PRDX3 in promoting tumour progression.